Selected research
Market Outlook & Growth Opportunities
Global NC Immunoassay Membrane Market Outlook and Growth Opportunities 2026
Market perspective
The global NC Immunoassay Membrane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for NC Immunoassay Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for NC Immunoassay Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for NC Immunoassay Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the NC Immunoassay Membrane market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the NC Immunoassay Membrane market include Merck, Sartorius, Danaher (Cytiva), Advantec, Advanced Microdevices (MDI), Cobetter, Zhejiang Tailin Bioengineering, BSK Basic and Tianren, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global NC Immunoassay Membrane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of NC Immunoassay Membrane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents NC Immunoassay Membrane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NC Immunoassay Membrane market size, projected growth trends, production technologies, key applications, and end-use industries.
NC Immunoassay Membrane Segment by Company
Merck
Sartorius
Danaher (Cytiva)
Advantec
Advanced Microdevices (MDI)
Cobetter
Zhejiang Tailin Bioengineering
BSK Basic
Tianren
Beijia New Material
Kingfa
Equinox Biotech
NC Immunoassay Membrane Segment by Type
Thickness max. 250 µm
Thickness above 250 µm
NC Immunoassay Membrane Segment by Application
Medical Diagnostics and Point-of-Care (POC)
Drug of Abuse Testing
Food Safety and Environmental
Other Applications
NC Immunoassay Membrane Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global NC Immunoassay Membrane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions NC Immunoassay Membrane market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify NC Immunoassay Membrane significant trends, drivers, influence factors in global and regions.
6. To analyze NC Immunoassay Membrane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NC Immunoassay Membrane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NC Immunoassay Membrane and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NC Immunoassay Membrane.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the NC Immunoassay Membrane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NC Immunoassay Membrane industry.
Chapter 3: Detailed analysis of NC Immunoassay Membrane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of NC Immunoassay Membrane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of NC Immunoassay Membrane in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Thickness max. 250 µm
- Thickness above 250 µm
Applications
- Medical Diagnostics and Point-of-Care (POC)
- Drug of Abuse Testing
- Food Safety and Environmental
- Other Applications
Companies covered
- Merck
- Sartorius
- Danaher (Cytiva)
- Advantec
- Advanced Microdevices (MDI)
- Cobetter
- Zhejiang Tailin Bioengineering
- BSK Basic
- Tianren
- Beijia New Material
- Kingfa
- Equinox Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global NC Immunoassay Membrane Sales Value (2021-2032)
- 1.2.2 Global NC Immunoassay Membrane Sales Volume (2021-2032)
- 1.2.3 Global NC Immunoassay Membrane Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 NC Immunoassay Membrane Market Dynamics
- 2.1 NC Immunoassay Membrane Industry Trends
- 2.2 NC Immunoassay Membrane Industry Drivers
- 2.3 NC Immunoassay Membrane Industry Opportunities and Challenges
- 2.4 NC Immunoassay Membrane Industry Restraints
3 NC Immunoassay Membrane Market by Company
- 3.1 Global NC Immunoassay Membrane Company Revenue Ranking in 2025
- 3.2 Global NC Immunoassay Membrane Revenue by Company (2021-2026)
- 3.3 Global NC Immunoassay Membrane Sales Volume by Company (2021-2026)
- 3.4 Global NC Immunoassay Membrane Average Price by Company (2021-2026)
- 3.5 Global NC Immunoassay Membrane Company Ranking (2024-2026)
- 3.6 Global NC Immunoassay Membrane Company Manufacturing Base and Headquarters
- 3.7 Global NC Immunoassay Membrane Company Product Type and Application
- 3.8 Global NC Immunoassay Membrane Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global NC Immunoassay Membrane Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 NC Immunoassay Membrane Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 NC Immunoassay Membrane Market by Type
- 4.1 NC Immunoassay Membrane Type Introduction
- 4.1.1 Thickness max. 250 µm
- 4.1.2 Thickness above 250 µm
- 4.2 Global NC Immunoassay Membrane Sales Volume by Type
- 4.2.1 Global NC Immunoassay Membrane Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global NC Immunoassay Membrane Sales Volume by Type (2021-2032)
- 4.2.3 Global NC Immunoassay Membrane Sales Volume Share by Type (2021-2032)
- 4.3 Global NC Immunoassay Membrane Sales Value by Type
- 4.3.1 Global NC Immunoassay Membrane Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global NC Immunoassay Membrane Sales Value by Type (2021-2032)
- 4.3.3 Global NC Immunoassay Membrane Sales Value Share by Type (2021-2032)
5 NC Immunoassay Membrane Market by Application
- 5.1 NC Immunoassay Membrane Application Introduction
- 5.1.1 Medical Diagnostics and Point-of-Care (POC)
- 5.1.2 Drug of Abuse Testing
- 5.1.3 Food Safety and Environmental
- 5.1.4 Other Applications
- 5.2 Global NC Immunoassay Membrane Sales Volume by Application
- 5.2.1 Global NC Immunoassay Membrane Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global NC Immunoassay Membrane Sales Volume by Application (2021-2032)
- 5.2.3 Global NC Immunoassay Membrane Sales Volume Share by Application (2021-2032)
- 5.3 Global NC Immunoassay Membrane Sales Value by Application
- 5.3.1 Global NC Immunoassay Membrane Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global NC Immunoassay Membrane Sales Value by Application (2021-2032)
- 5.3.3 Global NC Immunoassay Membrane Sales Value Share by Application (2021-2032)
6 NC Immunoassay Membrane Regional Sales and Value Analysis
- 6.1 Global NC Immunoassay Membrane Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global NC Immunoassay Membrane Sales by Region (2021-2032)
- 6.2.1 Global NC Immunoassay Membrane Sales by Region: 2021-2026
- 6.2.2 Global NC Immunoassay Membrane Sales by Region (2027-2032)
- 6.3 Global NC Immunoassay Membrane Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global NC Immunoassay Membrane Sales Value by Region (2021-2032)
- 6.4.1 Global NC Immunoassay Membrane Sales Value by Region: 2021-2026
- 6.4.2 Global NC Immunoassay Membrane Sales Value by Region (2027-2032)
- 6.5 Global NC Immunoassay Membrane Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America NC Immunoassay Membrane Sales Value (2021-2032)
- 6.6.2 North America NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe NC Immunoassay Membrane Sales Value (2021-2032)
- 6.7.2 Europe NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific NC Immunoassay Membrane Sales Value (2021-2032)
- 6.8.2 Asia-Pacific NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America NC Immunoassay Membrane Sales Value (2021-2032)
- 6.9.2 South America NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa NC Immunoassay Membrane Sales Value (2021-2032)
- 6.10.2 Middle East & Africa NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
7 NC Immunoassay Membrane Country-level Sales and Value Analysis
- 7.1 Global NC Immunoassay Membrane Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global NC Immunoassay Membrane Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global NC Immunoassay Membrane Sales by Country (2021-2032)
- 7.3.1 Global NC Immunoassay Membrane Sales by Country (2021-2026)
- 7.3.2 Global NC Immunoassay Membrane Sales by Country (2027-2032)
- 7.4 Global NC Immunoassay Membrane Sales Value by Country (2021-2032)
- 7.4.1 Global NC Immunoassay Membrane Sales Value by Country (2021-2026)
- 7.4.2 Global NC Immunoassay Membrane Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.5.2 USA NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.9.2 France NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.16.2 China NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.19.2 India NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Merck NC Immunoassay Membrane Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Sartorius
- 8.2.1 Sartorius Company Information
- 8.2.2 Sartorius Business Overview
- 8.2.3 Sartorius NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Sartorius NC Immunoassay Membrane Product Portfolio
- 8.2.5 Sartorius Recent Developments
- 8.3 Danaher (Cytiva)
- 8.3.1 Danaher (Cytiva) Company Information
- 8.3.2 Danaher (Cytiva) Business Overview
- 8.3.3 Danaher (Cytiva) NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Danaher (Cytiva) NC Immunoassay Membrane Product Portfolio
- 8.3.5 Danaher (Cytiva) Recent Developments
- 8.4 Advantec
- 8.4.1 Advantec Company Information
- 8.4.2 Advantec Business Overview
- 8.4.3 Advantec NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Advantec NC Immunoassay Membrane Product Portfolio
- 8.4.5 Advantec Recent Developments
- 8.5 Advanced Microdevices (MDI)
- 8.5.1 Advanced Microdevices (MDI) Company Information
- 8.5.2 Advanced Microdevices (MDI) Business Overview
- 8.5.3 Advanced Microdevices (MDI) NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Advanced Microdevices (MDI) NC Immunoassay Membrane Product Portfolio
- 8.5.5 Advanced Microdevices (MDI) Recent Developments
- 8.6 Cobetter
- 8.6.1 Cobetter Company Information
- 8.6.2 Cobetter Business Overview
- 8.6.3 Cobetter NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Cobetter NC Immunoassay Membrane Product Portfolio
- 8.6.5 Cobetter Recent Developments
- 8.7 Zhejiang Tailin Bioengineering
- 8.7.1 Zhejiang Tailin Bioengineering Company Information
- 8.7.2 Zhejiang Tailin Bioengineering Business Overview
- 8.7.3 Zhejiang Tailin Bioengineering NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Zhejiang Tailin Bioengineering NC Immunoassay Membrane Product Portfolio
- 8.7.5 Zhejiang Tailin Bioengineering Recent Developments
- 8.8 BSK Basic
- 8.8.1 BSK Basic Company Information
- 8.8.2 BSK Basic Business Overview
- 8.8.3 BSK Basic NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.8.4 BSK Basic NC Immunoassay Membrane Product Portfolio
- 8.8.5 BSK Basic Recent Developments
- 8.9 Tianren
- 8.9.1 Tianren Company Information
- 8.9.2 Tianren Business Overview
- 8.9.3 Tianren NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Tianren NC Immunoassay Membrane Product Portfolio
- 8.9.5 Tianren Recent Developments
- 8.10 Beijia New Material
- 8.10.1 Beijia New Material Company Information
- 8.10.2 Beijia New Material Business Overview
- 8.10.3 Beijia New Material NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Beijia New Material NC Immunoassay Membrane Product Portfolio
- 8.10.5 Beijia New Material Recent Developments
- 8.11 Kingfa
- 8.11.1 Kingfa Company Information
- 8.11.2 Kingfa Business Overview
- 8.11.3 Kingfa NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Kingfa NC Immunoassay Membrane Product Portfolio
- 8.11.5 Kingfa Recent Developments
- 8.12 Equinox Biotech
- 8.12.1 Equinox Biotech Company Information
- 8.12.2 Equinox Biotech Business Overview
- 8.12.3 Equinox Biotech NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Equinox Biotech NC Immunoassay Membrane Product Portfolio
- 8.12.5 Equinox Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 NC Immunoassay Membrane Value Chain Analysis
- 9.1.1 NC Immunoassay Membrane Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 NC Immunoassay Membrane Sales Mode & Process
- 9.2 NC Immunoassay Membrane Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 NC Immunoassay Membrane Distributors
- 9.2.3 NC Immunoassay Membrane Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst